U.S. Patents Awarded to Inventors in Pennsylvania (Feb. 16)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Feb. 16 -- The following federal patents were awarded to inventors in Pennsylvania.

*** Rheonix Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Rheonix, Ithaca, N.Y., has been assigned a patent (8,372,355) developed by Peng Zhou, Newtown, Pa., and Lincoln C. Young, Ithaca, N.Y., for a "microfluidic chips and assay systems." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The systems and methods described herein include a microfluidic chip having a plurality of microfeatures interconnected to provide a configurable fluid transport system for processing at least one reagent. Inserts are provided to removably interfit into one or more of the microfeatures of the chip, wherein the inserts include sites for interactions with the reagent. As will be seen from the following description, the microfluidic chip and the inserts provide an efficient and accurate approach for conducting parallel assays." The patent application was filed on May 19, 2011 (13/111,137). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,355&OS=8,372,355&RS=8,372,355 Written by Arpi Sharma; edited by Anand Kumar.

*** Sythes USA Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Sythes USA, West Chester, Pa., has been assigned a patent (8,372,073) developed by Mindy Lynn Hoffman, Pottstown, Pa., Charles Dean Preston II, Fort Walton Beach, Fla., and Michael Charles Mazzio, Schwenksville, Pa., for a "multi-pin clamp and rod attachment." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A fixation rod clamp is for coupling a bone pin locking assembly to a bone fixation rod. The clamp comprises a rod attachment portion including a jaw portion and a coupling portion, the jaw portion having first and second opposing jaws extending in a first direction, the jaws forming an opening there between configured to receive the bone fixation rod, the coupling portion extending from the jaw portion in a second direction; and a coupling having a pin vise cooperating portion to engage the bone pin locking assembly and a clamp cooperating portion configured to receive the coupling portion. The jaw portion is configured to engage the bone fixation rod when the bone fixation rod is located within the opposing jaws to thereby mechanically couple the bone pin locking assembly to the bone fixation rod." The patent application was filed on March 2, 2010 (12/715,797). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,72,073.PN.&OS=PN/83,72,073&RS=PN/83,72,073 Written by Amal Ahmed; edited by Jaya Anand.

*** Great River Energy Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Great River Energy, Maple Grove, Minn., has been assigned a patent (8,372,185) developed by eight co-inventors for an "apparatus and method of enhancing the quality of high-moisture materials and separating and concentrating organic and/or non-organic material contained therein." The co-inventors are Charles W. Bullinger, Bismarck, N.D., Mark A. Ness, Underwood, N.D., Nenad Sarunac, Easton, Pa., Edward K. Levy, Bethlehem, Pa., Richard S. Weinstein, Bismarck, N.D., James R. Dennis, Bismarck, N.D., Matthew P. Coughlin, Hibbing, Minn., and John M. Wheeldon, Birmingham, Ala.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention harvests and utilizes fluidized bed drying technology and waste heat streams augmented by other available heat sources to dry feedstock or fuel. This method is useful in many industries, including coal-fired power plants. Coal is dried using the present invention before it goes to coal pulverizers and on to the furnace/boiler arrangement to improve boiler efficiency and reduce emissions. This is all completed in a low-temperature, open-air system. Also included is an apparatus for segregating particulate by density and/or size including a fluidizing bed having a particulate receiving inlet for receiving particulate to be fluidized. This is useful for segregating contaminants like sulfur and mercury from the product stream." The patent application was filed on Oct. 10, 2011 (13/269,868). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,72,185.PN.&OS=PN/83,72,185&RS=PN/83,72,185 Written by Amal Ahmed; edited by Jaya Anand.

*** E. I. du Pont de Nemours Assigned Patent ALEXANDRIA, Va., Feb. 16 -- E. I. du Pont de Nemours, Wilmington, Del., has been assigned a patent (8,372,179) developed by five co-inventors for an "ore reduction process using carbon based materials having a low sulfur content and titanium oxide and iron metallization product therefrom." The co-inventors are John James Barnes, Hockessin, Del., Stephen Erwin Lyke, Wilmington, Del., Dat Nguyen, Chadds Ford, Pa., Joseph M. Shekiro Jr., Newark, Del., and Guangliang Liu, Wilmington, Del.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is one or more processes for producing separable iron and titanium oxides from an ore comprising titanium oxide and iron oxide, comprising: (a) forming agglomerates comprising carbon-based material and the ore, the quantity of carbon of the agglomerates being at least sufficient for forming a ferrous oxide-containing molten slag, at an elevated temperature; (b) introducing the agglomerates onto a bed of carbon-based material in a moving hearth furnace, wherein the carbon-based materials used for both the agglomerates and the bed have a low sulfur content; (c) heating the agglomerates in the moving hearth furnace to a temperature sufficient for liquefying the agglomerates to produce a liquid comprising ferrous oxide-containing slag; (d) metallizing the ferrous oxide of the slag by reaction of the ferrous oxide and the carbon of the carbon bed at a furnace temperature sufficient for maintaining the slag in a liquid state; (e) solidifying the slag after metallization of the ferrous oxide to form a matrix of titanium oxide-rich slag having a plurality of metallic iron granules distributed there through; and (f) separating the metallic iron granules from the slag, the slag comprising greater than 85% titanium dioxide based on the entire weight of the matrix after separation of the metallic iron." The patent application was filed on Oct. 14, 2008 (12/680,393). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,72,179.PN.&OS=PN/83,72,179&RS=PN/83,72,179 Written by Amal Ahmed; edited by Jaya Anand.

*** Bristol-Myers Squibb Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,372,837) developed by four co-inventors for a "pyridone and pyridazone analogues as GPR119 modulators." The co-inventors are Dean A. Wacker, Yardley, Pa., Karen A. Rossi, Newtown, Pa., Ying Wang, New Hope, Pa., and Gang Wu, Princeton, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel compounds of structure Formula (I) or an enantiomer, a diastereomer, or a pharmaceutically acceptable salt thereof, wherein Z, R.sup.1, R.sup.2, R.sup.21, T.sup.1, T.sup.2, T.sup.3 and T.sup.4 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds. ##STR00001##." The patent application was filed on July 15, 2009 (13/003,914). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,837&OS=8,372,837&RS=8,372,837 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Merck, Sharp & Dohme Assigned Patent for CGRP Receptor Antagonists with Tertiary Amide, Sulfonamide, Carbamate and Urea end Groups ALEXANDRIA, Va., Feb. 16 -- Merck, Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,372,859) developed by five co-inventors for "CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups." The co-inventors are Michael R. Wood, Harleysville, Pa., June Kim, Collegeville, Pa., Melody McWherter, Boyertown, Pa., Harold G. Selnick, Ambler, Pa., and Kathy Schirripa, Quakertown, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds of formula I: ##STR00001## (wherein variables A, m, n, J, R.sup.e, R.sup.f, R.sup.4, E.sup.a, E.sup.b, E.sup.c, R.sup.PG and Y are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine; and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved." The patent application was filed on April 7, 2008 (12/594,993). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,859&OS=8,372,859&RS=8,372,859 Written by Neha Bharti; edited by Jaya Anand.

*** GlaxoSmithKline Assigned Patent ALEXANDRIA, Va., Feb. 16 -- GlaxoSmithKline, Philadelphia, has been assigned a patent (8,372,875) developed by Jeffrey K. Kerns, King of Prussia, Pa., for "indole carboxamides as IKK2 inhibitors." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is directed to novel indole carboxamide compounds. Specifically, the invention is directed to compounds according to formula (I): ##STR00001## wherein R1, R2, R3, R4, and m are as defined herein. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKK.beta.) activity, such as rheumatoid arthritis, asthma, rhinitis, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention." The patent application was filed on Oct. 24, 2011 (13/279,434). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,875&OS=8,372,875&RS=8,372,875 Written by Neha Bharti; edited by Jaya Anand.

*** University of Illinois Assigned Patent ALEXANDRIA, Va., Feb. 16 -- The University of Illinois, Urbana, Ill., has been assigned a patent (8,372,636) developed by four co-inventors for "yeast cell surface display of proteins and uses thereof." The co-inventors are K. Dane Wittrup, Chestnut Hill, Mass., David M. Kranz, Champaign, Ill., Michele Kieke, Urbana, Ill., and Eric T. Boder, Media, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a genetic method for tethering polypeptides to the yeast cell wall in a form accessible for binding to macromolecules. Combining this method with fluorescence-activated cell sorting provides a means of selecting proteins with increased or decreased affinity for another molecule, altered specificity, or conditional binding. Also provided is a method for genetic fusion of the N terminus of a polypeptide of interest to the C-terminus of the yeast Aga2p cell wall protein. The outer wall of each yeast cell can display approximately 10.sup.4 protein agglutinins. The native agglutinins serve as specific adhesion contacts to fuse yeast cells of opposite mating type during mating. In effect, yeast has evolved a platform for protein-protein binding without steric hindrance from cell wall components. As one embodiment, attaching an scFv antibody fragment to the Aga2p agglutinin effectively mimics the cell surface display of antibodies by B cells in the immune system for affinity maturation in vivo. As another embodiment, T cell receptor mutants can be isolated by this method that are efficiently displayed on the yeast cell surface, providing a means of altering T cell receptor binding affinity and specificity by library screening." The patent application was filed on Dec. 16, 2008 (12/316,916). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,636&OS=8,372,636&RS=8,372,636 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Incyte Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Incyte, Wilmington, Del., has been assigned a patent (8,372,870) developed by Andrew P. Combs, Kennett Square, Pa., and Eddy W. Yue, Landenberg, Pa., for "modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof." The patent application was filed on Aug. 29, 2011 (13/220,406). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,870&OS=8,372,870&RS=8,372,870 Written by Neha Bharti; edited by Jaya Anand.

*** Air Products and Chemicals Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Air Products and Chemicals, Allentown, Pa., has been assigned a patent (8,372,756) developed by Glenn Michael Mitchell, Sellersville, Pa., Stephen Andrew Motika, Kutztown, Pa., and Andrew David Johnson, Doylestown, Pa., for a "selective etching of silicon dioxide compositions." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for selectively etching a material comprising SiO.sub.2 over silicon, the method comprising the steps of: placing a silicon substrate comprising a layer of a material comprising SiO.sub.2 within a reactor chamber equipped with an energy source; creating a vacuum within the chamber; introducing into the reactor chamber a reactive gas mixture comprising a fluorine compound, a polymerizable fluorocarbon, and an inert gas, wherein the reactive gas mixture is substantially free of added oxygen; activating the energy source to form a plasma activated reactive etching gas mixture within the chamber; and selectively etching the material comprising SiO.sub.2 preferentially to the silicon substrate." The patent application was filed on July 16, 2009 (12/504,064). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,756&OS=8,372,756&RS=8,372,756 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Geisinger Clinic Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Geisinger Clinic, Danville, Pa., has been assigned a patent (8,372,043) developed by five co-inventors for "devices and methods for fluid administration." The co-inventors are Kevin Grimm, Danville, Pa., Lauren Marie Shafer, Whitehall, Pa., Travis Snyer, Pittsburgh, Rachel Elise Zielinski, Manchester, Pa., and Daniel George Johnson, New Columbia, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Improved fluid delivery devices and systems are disclosed, including drug delivery devices and systems, and methods that permit, inter alia, the rapid sequential delivery of two or more fluids to a single external fluid flow or intravenous line." The patent application was filed on May 1, 2008 (12/598,103). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,372,043&OS=8,372,043&RS=8,372,043 Written by Neha Bharti; edited by Jaya Anand.

*** Rohm and Haas Electronic Materials Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Rohm and Haas Electronic Materials, Marlborough, Mass., has been assigned a patent (8,372,485) developed by David Mosley, Lafayette Hill, Pa., and David Thorsen, Pitman, N.J., for a "gallium ink and methods of making and using same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A gallium ink is provided, comprising, as initial components: a gallium component comprising gallium; a stabilizing component; an additive; and, a liquid carrier; wherein the gallium ink is a stable dispersion. Also provided are methods of preparing the gallium ink and for using the gallium ink in the preparation of semiconductor films (e.g., in the deposition of a CIGS layer for use in photovoltaic devices)." The patent application was filed on Feb. 18, 2011 (13/030,171). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,485.PN.&OS=PN/8,372,485&RS=PN/8,372,485 Written by Kusum Sangma; edited by Anand Kumar.

*** E.I. du Pont de Nemours Assigned Patent for Organic Electronic Device ALEXANDRIA, Va., Feb. 16 -- E.I. du Pont de Nemours, Wilmington, Del., has been assigned a patent (8,372,525) developed by five co-inventors for an organic electronic device. The co-inventors are Daniel David Lecloux, Wilmington, Del., Reid John Chesterfield, Wilmington, Del., Jeffrey A. Merlo, Wilmington, Del., Eric Maurice Smith, Hockessin, Del., and Nora Sabina Radu, Landenberg, Pa.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "There is provided an active layer containing a dopant material and a host material, wherein the host material has an HPLC purity of at least 99.9% and an impurity absorbance no greater than 0.01. There is also provided an electronic device containing the active layer." The patent application was filed on Nov. 13, 2007 (11/939,015). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,525.PN.&OS=PN/8,372,525&RS=PN/8,372,525 Written by Kusum Sangma; edited by Anand Kumar.

*** Butamax(TM) Advanced Biofuels Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Butamax(TM) Advanced Biofuels, Wilmington, Del., has been assigned a patent (8,372,612) developed by Robert A. Larossa, Chadds Ford, Pa., Dana R. Smulski, Wilmington, Del., and Vasantha Nagarajan, Wilmington, Del., for a "production of four carbon alcohols using improved strain." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Using screening of transposon random insertion mutants, genes involved in accumulation of (p)ppGpp were found to be involved in bacterial cell response to butanol. Reduced production of proteins with enzymatic activity for (p)ppGpp biosynthesis confers increased butanol tolerance. Bacterial strains with reduced (p)ppGpp accumulation and having a butanol or 2-butanone biosynthetic pathway are useful for production of butanol or 2-butanone." The patent application was filed on Dec. 9, 2008 (12/330,530). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,612.PN.&OS=PN/8,372,612&RS=PN/8,372,612 Written by Kusum Sangma; edited by Anand Kumar.

*** Momentive Performance Materials Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Momentive Performance Materials, Albany, N.Y., has been assigned a patent (8,372,515) developed by Christopher M. Byrne, Mohegan Lake, N.Y., George Policello, Ossining, N.Y., and Suresh Rajaraman, Macungie, Pa., for a "silane coating compositions containing silicon-based polyether copolymers, methods for coating metal surfaces and articles made therefrom." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A silane coating composition containing a silicon-based copolymer, a method for treating the surfaces of a metal such as steel, zinc-coated steels, or aluminum, to provide for the formation of a uniform conversion and/or passivation coating which increases the corrosion resistance of bare or painted metal and/or the adhesion properties of the metal, along with a metal having a conversion and/or passivation coating applied thereto are disclosed. Methods of the invention include contacting the requisite metal surface with an aqueous solution of a silane compound and a silicon-based polyether copolymer." The patent application was filed on Jan. 8, 2010 (12/684,326). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,515.PN.&OS=PN/8,372,515&RS=PN/8,372,515 Written by Kusum Sangma; edited by Anand Kumar.

*** Immunomedics Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Immunomedics, Morris Plains, N.J., has been assigned a patent (8,372,603) developed by six co-inventors for a "mammalian cell lines for increasing longevity and protein yield from a cell culture." The co-inventors are David M. Goldenberg, Mendham, N.J., Zhengxing Qu, Warren, N.J., Chien-Hsing Chang, Downingtown, Pa., Edmund A. Rossi, Woodland Park, N.J., Jeng-Dar Yang, Bedminster, N.J., and Diane Nordstrom, Rockaway, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are compositions and methods for increasing the longevity of a cell culture and permitting the increased production of proteins, preferably recombinant proteins, such as antibodies, peptides, enzymes, growth factors, interleukins, interferons, hormones, and vaccines. Cells transfected with an apoptosis-inhibiting gene or vector, such as a triple mutant Bcl-2 gene, can survive longer in culture, resulting in extension of the state and yield of protein biosynthesis. Such transfected cells exhibit maximal cell densities that equal or exceed the maximal density achieved by the parent cell lines. Transfected cells can also be pre-adapted for growth in serum-free medium, greatly decreasing the time required to obtain protein production in serum-free medium. In certain methods, the pre-adapted cells can be used for protein production following transformation under serum-free conditions. The method preferably involves eukaryotic cells, more preferably mammalian cells." The patent application was filed on March 7, 2012 (13/413,871). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,603.PN.&OS=PN/8,372,603&RS=PN/8,372,603 Written by Kusum Sangma; edited by Anand Kumar.

*** BASF Assigned Patent ALEXANDRIA, Va., Feb. 16 -- BASF, Florham Park, N.J., has been assigned a patent (8,372,477) developed by seven co-inventors for a "polymeric trap with adsorbent." The co-inventors are Mark T. Buelow, Phillipsburg, N.J., Laif R. Alden, Feasterville, Pa., John Kauffman, Hazlet, N.J., John J. Steger, Pittstown, N.J., William McMaster, Berkeley Heights, N.J., Zhenguo Liu, Flanders, N.J., and Raghuram Gummaraju, Kendall Park, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of adhering a particulate material, such as a hydrocarbon adsorbent material and/or a catalytic material, to a plastic surface, and products comprising the adhered material are disclosed." The patent application was filed on June 3, 2010 (12/793,586). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,477.PN.&OS=PN/8,372,477&RS=PN/8,372,477 Written by Kusum Sangma; edited by Anand Kumar.

*** mPhase Technologies Assigned Patent ALEXANDRIA, Va., Feb. 16 -- mPhase Technologies, Little Falls, N.J., has been assigned a patent (8,372,531) developed by Fred Allen, Princeton Junction, N.J., and Eran Turi, Richboro, Pa., for a reserve battery system.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A reserve battery that is activated via a low energy mechanical force. The reserve battery generally includes a battery case having an electrolyte compartment at a first end and an electrode compartment at a second end, a first terminal having an external button connected to the case at the first end, and a second terminal connected to the case at the second end. A movable ampoule is movably positioned within the electrolyte compartment. A bias member is located within the case between the external button and the ampoule and a porous cutter is positioned within the case between the electrodes and the ampoule and supported by an inverted U-shaped support structure. When an external force is applied to the external button, the bias member transfers an internal force to the ampoule to cause the ampoule to engage the cutter and allow the electrolyte to release thus activating the battery." The patent application was filed on March 2, 2010 (12/715,608). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,531.PN.&OS=PN/8,372,531&RS=PN/8,372,531 Written by Kusum Sangma; edited by Anand Kumar.

*** Wyeth Assigned Patent ALEXANDRIA, Va., Feb. 16 -- Wyeth, Madison, N.J., has been assigned a patent (8,372,625) developed by nine co-inventors for "polynucleotides encoding antagonist antibodies against GDF-8." The co-inventors are Frank S. Walsh, Bryn Mawr, Pa., Margaret M. Zaleska, Narberth, Pa., David S. Howland, Yardley, Pa., Lioudmila Tchistiakova, Andover, Mass., Riyez Karim, North Andover, Mass., Pamela Kelley, Reading, Pa., Xiang-Yang Tan, Reading, Mass., Seung Poon Kwak, Ewing, N.J., and Menelas N. Pangalos, Pennington, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention." The patent application was filed on March 2, 2011 (13/038,954). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,372,625.PN.&OS=PN/8,372,625&RS=PN/8,372,625 Written by Kusum Sangma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1114682 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]